Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips (PHG) announces the FDA clearance for its Zenition 30 mobile C-arm, which is intended to aid in image-guided procedures at a relatively affordable cost.

Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries

Philips (PHG) announces a consent decree with the U.S. government and FDA over Respironics' business recalls.

Philips (PHG) Agrees to a Consent Decree With DOJ and FDA

Philips climbed on Wednesday morning after details of an agreement with the US over its sale of potentially dangerous breathing devices in 2021 were revealed. Millions of the devices have already been recalled over fears that foam used to reduce noise could break down and become toxic and potentially cause cancer.

Philips climbs as US deal on sleep apnea machines revealed

Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, sending shares in the Dutch health technology firm up almost 3% on Wednesday.

Philips announces terms of US government deal on sleep apnea machines

Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respiratory care devices in the U.S. but will allow for exports.

Philips shares climb after finalizing pact with U.S. over device sales

Philips said it reached a final agreement with the U.S. Justice Department and Food and Drug Administration on terms of a settlement related its Respironics ventilators, and backed its medium-term guidance.

Philips Reaches Final Pact With U.S. Govt. on Ventilator Recall

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips' subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA.  As previously stated: The consent decree primarily focuses on Philips Respironics' business operations in the US.

Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward

A U.S. federal court issued a decree to restrict the production and sale of Philips' new sleep apnea machines at several facilities in the country, the Food and Drug Administration said on Tuesday.

US federal court orders to restrict production of Philips' sleep apnea devices

Philips (PHG) partners with smartQare to integrate the latter's viQtor solution, boosting its patient monitoring solutions portfolio.

Philips (PHG) Boosts Patient Monitoring With smartQare Deal

April 4, 2024  Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC

Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges

Campaign encourages shavers and groomers to embrace personal growth and shape their true selves with Philips Norelco  CAMBRIDGE, Mass. , April 2, 2024 /PRNewswire/ --  Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership with acclaimed actor and facial hair enthusiast Adam Scott.

Philips Norelco Taps Actor Adam Scott for New Campaign

March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the Supervisory Board, with effect from May 7, 2024.

Philips convenes the Annual General Meeting of Shareholders 2024

Medical device manufacturer Philips is betting on innovation as artificial intelligence (AI) transforms the health care industry, its chief executive told AFP in an interview on Tuesday, as the company looks to turn the page on a massive recall of defective sleep respirators.

Philips looks to AI as seeks to turn the page on defective respirators

March 19, 2024    Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips' extensive global R&D programs and collaborations position the company at the forefront of health technology innovation.

Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office

Philips (PHG) adds Philips One for Kids toothbrush into its Sonicare family, boosting its Personal Health business.

Philips (PHG) Expands Sonicare Portfolio With Latest Launch

Philips (PHG) collaborates with Amazon Web Services to boost cloud-based pathology solutions. It will enable pathology laboratories to use digital processes to improve analytical capabilities.

Philips (PHG), AWS Unite to Scale Digital Pathology Solutions

Philips (PHG) launches #ShareTheCare brand positioning campaign for Philips Avent, bolstering the Personal Health segment.

Philips (PHG) Aids Personal Health Business With New Campaign

Playfully designed Philips One for Kids helps kids ages 3 and up make good brushing habits easy CAMBRIDGE, Mass. , March 12, 2024 /PRNewswire/ -- Philips Sonicare launches Philips One for Kids to help children implement healthier oral healthcare routines with the push of a button.

Philips Sonicare Encourages Life-Long Healthy Habits with New Power Toothbrush for Kids

March 6, 2024 Company's innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included in the 2024 Clarivate Top 100 Global Innovator™ list . Philips' global R&D programs and collaborations aim to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Health technology leader Philips recognized as Clarivate Top 100 Global Innovator

Philips (PHG) announces its latest innovation, Philips CT 5300, which leverages the power of AI at every stage in CT scanner operation to enhance productivity and diagnostic capabilities.

Philips' (PHG) CT 5300 to Boost Diagnostic Capabilities

Philips (PHG) introduces AI-enabled Philips CT 5300 X-ray CT system, expanding its diagnostic imaging portfolio.

Philips (PHG) Aids Diagnostic Imaging With Philips CT 5300

February 29, 2024 New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips' latest innovation leverages the power of AI at every stage in CT scanner operation to enhance productivity and diagnostic capabilities of high-throughput, short-staffed radiology departments Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips CT 5300 system equipped with advanced AI capabilities designed to be used for diagnosis, interventional procedures and screening. The flexible X-ray CT system increases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.

Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024

Philips (PHG) announces its latest Azurion neuro biplane system, which aims to improve the diagnosis of stroke and major neurovascular diseases. The system is designed for superior patient care.

Philips' (PHG) New Innovation to Boost Neurovascular Diagnosis

February 28, 2024 At #ECR2024, company also debuting Europe's first mobile virtually helium-free MRI system Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more than 1,000 systems now installed worldwide. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare.

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

February 28, 2024 Proposal to appoint Ms. Hanneman as member of Philips' Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands –  Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, fulfilling the role of Chief Financial Officer (CFO), effective October 1, 2024.

News for Royal Philips Stock (PHG)